Conservest Capital Advisors’s Zimmer Biomet ZBH Stock Holding History

Conservest Capital Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-3,227	Closed	-$342K	–	90
2018 Q1	$342K	Hold	3,227	–	–	0.07%	58
2017 Q4	$378K	Buy	3,227 +6	+0.2%	+$678	0.08%	58
2017 Q3	$366K	Buy	3,221 +6	+0.2%	+$693	0.06%	66
2017 Q2	$401K	Buy	3,215 +8	+0.2%	+$948	0.09%	55
2017 Q1	$380K	Buy	+3,207	New	+$363K	0.08%	56

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Conservest Capital Advisors's ZBH Position: Q2 2018 in Review

Conservest Capital Advisors sold out of Zimmer Biomet (ZBH) in Q2 2018, closing a stake of 3,227 shares — an estimated $342K sold.

Conservest Capital Advisors first reported a position in ZBH in Q1 2017 and held it in 5 quarters. The position peaked at $401K in Q2 2017. 869 funds tracked by Wall St. Rank hold ZBH as of Q2 2018.

Conservest Capital Advisors reported no remaining Zimmer Biomet position as of Q2 2018 after selling out during the quarter.
Conservest Capital Advisors sold 3,227 Zimmer Biomet shares in Q2 2018, an estimated $342K.
Conservest Capital Advisors first reported a position in Zimmer Biomet in Q1 2017 and held it in 5 quarters.
Conservest Capital Advisors's Zimmer Biomet position peaked at $401K in Q2 2017.
869 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2018.

Based on Conservest Capital Advisors's 13F filing for Q2 2018, filed 9 Jul 2018.